INDIS: Innovative Nanostructured surface of Dental ImplantS
Reference number | |
Coordinator | Malmö Universitet - Malmö universitet Odontologiska fakulteten |
Funding from Vinnova | SEK 1 910 115 |
Project duration | October 2024 - September 2027 |
Status | Ongoing |
Venture | Eurostars |
Purpose and goal
Peri-implantitis, i.e., inflammation of the peri-implant soft connective tissue and progressive loss of implant-supporting bone, affects about 22% of the patients with dental implants. Peri-implantitis treatment is complex and unpredictable. Development of technologies contributing to prevention of disease seems crucial. The current project will evaluate a novel implant surface technology for its antimicrobial potential, together with its osseointegration capacity, both in-vitro and in-vivo.
Expected effects and result
The current project will disclose whether a novel implant surface technology exerts a relevant antimicrobial potential, without compromising osseointegration. If it is confirmed that this novel implant surface technology indeed exerts a relevant antimicrobial potential and does compromising osseointegration, then further studies, including clinical testing, should be performed to assess the potential of the technology in clinical settings and on the long-term.
Planned approach and implementation
The project includes in-vitro and in-vivo experiments, for example mechanical tests assessing the robustness of this surface modification, use in-vitro biofilm models, clinical plaque accumulation models etc.